CRBU vs ROL · rev $3.9M vs P/E 41, rev $1.99B
Caribou Biosciences Inc (CRBU) versus Rollins Inc (ROL) — a side-by-side from cached financials, not a winner call.
Caribou Biosciences Inc (CRBU) is a biotechnology company listed on US.
Rollins Inc (ROL) is a personal services company listed on NYSE.
Latest reported CRBU revenue for 2026-06-30 was $3.9M. Net income was -$49.4M. Revenue was up 62.5% from 2026-03-31 to 2026-06-30. CRBU currently screens at market cap $190.4M.
Latest reported ROL revenue for 2026-06-30 was $1.99B. Net income was $251.7M. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
CRBU currently screens at market cap $190.4M. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Not investment advice. Open the CRBU and ROL stock pages for the full models.
Not investment advice.